Azita Saleki-gerhardt sold $8.4M of AbbVie (ABBV)

Executed Aug 12 2025, disclosed Aug 14 2025, 2 days later.

Value, as filed

$8.4M

42,370 sh × $198.42

Executed

Aug 12 2025

the trade date, as filed

Disclosed

Aug 14 2025

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

AG Azita Saleki-gerhardt EVP, CHIEF OPERATIONS OFFICER profile →

Azita Saleki-gerhardt (EVP, CHIEF OPERATIONS OFFICER) filed 1 Form 4 report in the past 24 months (0 purchases, 1 sale), most often in AbbVie Inc. (ABBV). The largest single filing was $8.4M of ABBV (42,370 sh × $198.42, as filed), executed Aug 12 2025.

The name

ABBV AbbVie Inc. ABBV · Healthcare · 41 filings in 24 months ticker →

Healthcare · AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→